A proteomics-based approach for monoclonal antibody characterization.

Area of Science:

• Proteomics
• Immunology
• Biochemistry

Background:

• Monoclonal antibody (mAb) specificity determination traditionally requires purified antigens, which are often unavailable.
• Antigen unavailability is a significant bottleneck in monoclonal antibody production and characterization.
• Developing methods to define antibody specificity without pure antigens is crucial for advancing antibody-based research and therapeutics.

Purpose of the Study:

• To develop a universal proteomics-based strategy for defining monoclonal antibody specificity.
• To overcome the limitation of requiring purified antigens in antibody characterization.
• To provide a robust method for analyzing antibodies against complex biological mixtures.

Main Methods:

• Utilized proteomics techniques to analyze antibody binding to complex protein mixtures.
• Developed a generic scheme for antibody specificity determination.
• Applied the developed approach to various biological sample types.

Main Results:

• Successfully demonstrated the identification of antibodies targeting both major and minor protein components.
• Validated the approach's efficacy in characterizing antibodies against complex antigen mixtures.
• Showcased the ability to detect antibodies against contaminants within protein samples.

Conclusions:

• The developed proteomics approach effectively defines monoclonal antibody specificity without pure antigens.
• This method significantly enhances the characterization of antibodies against complex antigen mixtures.
• The strategy offers a powerful tool for antibody discovery and validation in proteomics research.